Edward Appiah Boateng1, Linda East. 1. School of Nursing, Midwifery & Physiotherapy, University of Nottingham, UK. guardian2405@yahoo.com
Abstract
BACKGROUND: This systematic review aims to generate evidence on which dialysis modality (in-centre haemodialysis HD, or peritoneal dialysis, PD) improves the quality of life (QOL) of end stage renal disease (ESRD) patients. METHODS: MEDLINE, CINAHL and EMBASE were searched from their inception to July 2010 for studies that compared QOL in both HD and PD patients. RESULTS: Only 26 of the 574 studies identified were included in this review. These were crosssectional, longitudinal or retrospective in design. QOL tools used include SF-36, Kidney Disease Quality of Life (KDQOL) and CHOICE Health Experience Questionnaire (CHEQ). PD patients mostly rate their QOL higher than HD patients. Yet HD patients may enjoy a relatively better QOL in the physical dimensions over time. Mental health components are comparable between both dialysis populations. CONCLUSION: There is no simple 'yes' or 'no' answer to the question of which dialysis modality improves QOL. However a good understanding of the evidence base will facilitate individual decision-making.
BACKGROUND: This systematic review aims to generate evidence on which dialysis modality (in-centre haemodialysis HD, or peritoneal dialysis, PD) improves the quality of life (QOL) of end stage renal disease (ESRD) patients. METHODS: MEDLINE, CINAHL and EMBASE were searched from their inception to July 2010 for studies that compared QOL in both HD and PDpatients. RESULTS: Only 26 of the 574 studies identified were included in this review. These were crosssectional, longitudinal or retrospective in design. QOL tools used include SF-36, Kidney Disease Quality of Life (KDQOL) and CHOICE Health Experience Questionnaire (CHEQ). PDpatients mostly rate their QOL higher than HDpatients. Yet HDpatients may enjoy a relatively better QOL in the physical dimensions over time. Mental health components are comparable between both dialysis populations. CONCLUSION: There is no simple 'yes' or 'no' answer to the question of which dialysis modality improves QOL. However a good understanding of the evidence base will facilitate individual decision-making.
Authors: Fabiane Rossi dos Santos Grincenkov; Natália Fernandes; Alfredo Chaoubah; Neimar da Silva Fernandes; Kleyton Bastos; Antonio Alberto Lopes; Abdul Rashid Qureshi; Fredric O Finkelstein; Roberto Pecoits-Filho; José Carolino Divino-Filho; Marcus Gomes Bastos Journal: Perit Dial Int Date: 2013 Nov-Dec Impact factor: 1.756
Authors: Fredric O Finkelstein; Kelli L Arsenault; Ana Taveras; Kwabena Awuah; Susan H Finkelstein Journal: Nat Rev Nephrol Date: 2012-10-23 Impact factor: 28.314
Authors: Tanjala S Purnell; Priscilla Auguste; Deidra C Crews; Julio Lamprea-Montealegre; Temitope Olufade; Raquel Greer; Patti Ephraim; Johanna Sheu; Daniel Kostecki; Neil R Powe; Hamid Rabb; Bernard Jaar; L Ebony Boulware Journal: Am J Kidney Dis Date: 2013-05-29 Impact factor: 8.860
Authors: Philip K T Li; Bruce F Culleton; Amaury Ariza; Jun-Young Do; David W Johnson; Mauricio Sanabria; Ty R Shockley; Ken Story; Andrey Vatazin; Mauro Verrelli; Alex W Yu; Joanne M Bargman Journal: J Am Soc Nephrol Date: 2013-08-15 Impact factor: 10.121
Authors: Agneta A Pagels; Birgitta Klang Söderkvist; Charlotte Medin; Britta Hylander; Susanne Heiwe Journal: Health Qual Life Outcomes Date: 2012-06-18 Impact factor: 3.186
Authors: Amanda L McGuire; Sophia C Bennett; Sally M Lansley; Natalia D Popowicz; Julius F Varano della Vergiliana; Daniel Wong; Y C Gary Lee; Aron Chakera Journal: PLoS One Date: 2015-03-05 Impact factor: 3.240
Authors: Katarzyna Kiliś-Pstrusińska; Anna Wasilewska; Anna Medyńska; Irena Bałasz-Chmielewska; Ryszard Grenda; Agnieszka Kluska-Jóźwiak; Beata Leszczyńska; Ilona Olszak-Szot; Monika Miklaszewska; Maria Szczepańska; Marcin Tkaczyk; Agnieszka Urzykowska; Katarzyna Zachwieja; Maria Zajączkowska; Helena Ziółkowska; Ilona Zagożdżon; Danuta Zwolińska Journal: Pediatr Nephrol Date: 2013-08-16 Impact factor: 3.714